[ad_1] Telitacicept Matches Belimumab in Controlling Childhood Lupus, Study Finds We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] High-Dose HCQ Tied to Better Symptom Control in SLE With Lower Adverse CV Events: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] Detailed mapping of CD4⁺ T cells from children with systemic lupus erythematosus (SLE) has revealed distinct immune cell subsets with likely roles in disease pathogenesis, according to a study led by Weill Cornell Medicine investigators. The findings are poised to redirect lupus research and open the door to more precise therapies that avoid broad…
[ad_1] Low Vitamin D Linked to Higher Mortality and Cardiovascular Risk among Lupus Patients: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] AstraZeneca’s hopes of a big new indication for respiratory drug Fasenra in chronic obstructive pulmonary disease (COPD) have been dashed by a negative phase 3 trial. The RESOLUTE study of IL-5 inhibitor Fasenra (benralizumab) showed some improvement with Fasenra compared to placebo in reducing COPD exacerbations, or attacks, that signal progression of the debilitating…